Natus to Participate in Raymond James Virtual Human Health Innovation Conference
Rhea-AI Summary
Natus Medical Incorporated (NASDAQ: NTUS) announced its participation in the Raymond James Virtual Human Health Innovation Conference on June 16, 2020. CEO Jonathan Kennedy and CFO Drew Davies will hold one-on-one meetings with institutional investors. Interested investors can schedule meetings through a Raymond James representative. Natus specializes in medical device solutions for diagnosing and treating central nervous and sensory system disorders across all ages.
Positive
- None.
Negative
- None.
News Market Reaction – NTUS
In the trading session that priced this news, NTUS gained 0.69%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PLEASANTON, Calif., June 11, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Jonathan Kennedy, President and Chief Executive Officer and Drew Davies, Executive Vice President and Chief Financial Officer will be hosting one-on-one meetings with institutional investors at the Raymond James Virtual Human Health Innovation Conference on Tuesday, June 16th. Investors interested in scheduling a meeting should contact a Raymond James representative.
About Natus Medical Incorporated
Natus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
Additional information about Natus Medical can be found at www.natus.com.
Natus Medical Incorporated
B. Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com